Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$245K Sell
1,904
-4
-0.2% -$468 0.05% 128
2026
Q1
$230K Buy
+1,908
New +$220K 0.06% 123
2024
Q4
Sell
-2,302
Closed -$264K 117
2024
Q3
$264K Buy
2,302
+290
+14% +$34.5K 0.09% 98
2024
Q2
$257K Sell
2,012
-49
-2% -$6.31K 0.09% 92
2024
Q1
$268K Buy
+2,061
New +$254K 0.1% 87

Other funds holding MRK

GSG Advisors's MRK Position: Q2 2026 in Review

GSG Advisors reduced its Merck (MRK) stake by 0.21% in Q2 2026, selling an estimated $468 and leaving 1,904 shares worth $245K. The position accounts for 0.05% of the portfolio, ranked #128.

GSG Advisors first reported a position in MRK in Q1 2024 and has held it in 5 quarters since. The position peaked at $268K in Q1 2024. 3,845 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • GSG Advisors held 1,904 shares of Merck worth $245K as of Q2 2026.
  • GSG Advisors sold 4 Merck shares in Q2 2026, an estimated $468.
  • Merck made up 0.05% of GSG Advisors's portfolio in Q2 2026, its #128 holding.
  • GSG Advisors first reported a position in Merck in Q1 2024 and has held it in 5 quarters since.
  • GSG Advisors's Merck position peaked at $268K in Q1 2024.
  • 3,845 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on GSG Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.